Bristol-Myers Squibb Company BDR (BMYB34)

Featured here, the Income Statement (earnings report) for Bristol-Myers Squibb Company BDR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

325.60 +2.08 (+0.64%)

05/06 Closed BRL Disclaimer

BMYB34 Income Statement

Total Revenue
Total Operating Expenses
Operating Income

Name	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Total Revenue	11,337	11,406	11,218	11,887	11,648
Revenue	11,337	11,406	11,218	11,887	11,648
Other Revenue, Total	0	0	0	0	0
Cost of Revenue, Total	2,512	2,520	2,267	2,575	2,419
Gross Profit	8,825	8,886	8,951	9,312	9,229
Total Operating Expenses	8,831	9,633	8,791	9,065	8,798
Selling/General/Admin. Expenses, Total	1,762	2,260	1,848	1,773	1,829
Research & Development	2,301	2,510	2,258	2,300	2,133
Depreciation / Amortization	-	-	-	-	-
Interest Expense (Income) - Net Operating	-262	-233	-307	-302	-311
Unusual Expense (Income)	-	-	-	-	-
Other Operating Expenses, Total	2,518	2,576	2,725	2,719	2,728
Operating Income	2,506	1,773	2,427	2,822	2,850
Interest Income (Expense), Net Non-Operating	-	-	-	-	-
Gain (Loss) on Sale of Assets	-135	166	-11	-254	-383
Other, Net	-129	-252	229	1,118	1,546
Net Income Before Taxes	2,770	1,859	2,209	1,958	1,687
Provision for Income Taxes	503	-166	601	529	404
Net Income After Taxes	2,267	2,025	1,608	1,429	1,283
Minority Interest	62	57	63	61	65
Equity In Affiliates	-	-	-	-	-
U.S GAAP Adjustment	-	-	-	-	-
Net Income Before Extraordinary Items	2,262	2,022	1,606	1,421	1,278
Total Extraordinary Items	0	0	0	0	0
Net Income	2,262	2,022	1,606	1,421	1,278
Total Adjustments to Net Income	0	0	0	0	0
Income Available to Common Excluding Extraordinary Items	2,262	2,022	1,606	1,421	1,278
Dilution Adjustment	1.09	-0.70	-5	2.66	1.24
Diluted Net Income	2,260.91	2,022.70	1,611	1,418.34	1,276.76
Diluted Weighted Average Shares	2,113	2,124	2,148	2,149	2,164
Diluted EPS Excluding Extraordinary Items	1.07	0.95	0.75	0.66	0.59
DPS - Common Stock Primary Issue	0.57	0.57	0.54	0.54	0.54
Diluted Normalized EPS	0.84	0.57	0.82	0.86	0.85

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.